Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hyttel

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Neuropharmacology|December 1, 1981
Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potentialJ Arnt, A V Christensen, J Hyttel
Acta Pharmacologica Et Toxicologica|July 1, 1980
Neuropharmacological properties of amitriptyline, nortriptyline and their metabolitesJ Hyttel, A V Christensen, B Fjalland
Psychopharmacology|January 1, 1984
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopramJ Hyttel, K F Overø, J Arnt
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neuroleptic classification: implications for tardive dyskinesiaJ Hyttel, A V Christensen, J Arnt
Acta Physiologica Scandinavica|November 1, 1984
The dopamine D-1 antagonist SCH 23390 inhibits apomorphine but not pergolide induced rotationM Herrera-Marschitz, J Hyttel, U Ungerstedt
Acta Pharmacologica Et Toxicologica|October 1, 1986
Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in ratsJ Arnt, J Hyttel, T Bach-Lauritsen
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985
Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainJ Arnt, A V Christensen, J Hyttel
Polish Journal of Pharmacology and Pharmacy|March 1, 1984
Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functionsJ Arnt, J Hyttel, K F Overø
Acta Pharmacologica Et Toxicologica|November 1, 1984
The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmittersJ Arnt, J Hyttel, J J Larsen
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1977
Peripheral and central muscarinic receptor affinity of psychotropic drugsB Fjalland, A V Christensen, J Hyttel
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Neuropharmacology|December 1, 1981
Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potentialJ Arnt, A V Christensen, J Hyttel
Acta Pharmacologica Et Toxicologica|July 1, 1980
Neuropharmacological properties of amitriptyline, nortriptyline and their metabolitesJ Hyttel, A V Christensen, B Fjalland
Psychopharmacology|January 1, 1984
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopramJ Hyttel, K F Overø, J Arnt
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neuroleptic classification: implications for tardive dyskinesiaJ Hyttel, A V Christensen, J Arnt
Acta Physiologica Scandinavica|November 1, 1984
The dopamine D-1 antagonist SCH 23390 inhibits apomorphine but not pergolide induced rotationM Herrera-Marschitz, J Hyttel, U Ungerstedt
Acta Pharmacologica Et Toxicologica|October 1, 1986
Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in ratsJ Arnt, J Hyttel, T Bach-Lauritsen
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985
Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainJ Arnt, A V Christensen, J Hyttel
Polish Journal of Pharmacology and Pharmacy|March 1, 1984
Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functionsJ Arnt, J Hyttel, K F Overø
Acta Pharmacologica Et Toxicologica|November 1, 1984
The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmittersJ Arnt, J Hyttel, J J Larsen
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1977
Peripheral and central muscarinic receptor affinity of psychotropic drugsB Fjalland, A V Christensen, J Hyttel
Pageof 10